SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Gustaf Edgren, Klaus Rostgaard, Senthil K. Vasan, Agneta Wikman, Rut Norda, Ole Birger Pedersen, Christian Erikstrup, Kaspar René Nielsen, Kjell Titlestad, Henrik Ullum, Mads Melbye, Olof Nyrén, Henrik Hjalgrim, The new Scandinavian Donations and Transfusions database (SCANDAT2): a blood safety resource with added versatility, Transfusion, 2015, 55, 5
  2. 2
    Peter Schubert, Brankica Culibrk, Simrath Karwal, Katherine Serrano, Elena Levin, Daniel Bu, Varsha Bhakta, William P. Sheffield, Raymond P. Goodrich, Dana V. Devine, Whole blood treated with riboflavin and ultraviolet light: quality assessment of all blood components produced by the buffy coat method, Transfusion, 2015, 55, 4
  3. 3
    Louis M. Katz, Emerging microbial threats to the United States blood supply, Current Opinion in Hematology, 2014, 21, 6, 509

    CrossRef

  4. 4
    M. P. Busch, Infectious risks of blood transfusions: Recent advances in testing technologies and new approaches to surveillance and decision-making, ISBT Science Series, 2014, 9, 1
  5. 5
    Massimo Morfini, Innovative approach for improved rFVIII concentrate, European Journal of Haematology, 2014, 93, 5
  6. 6
    Steven Kleinman, Michael P. Busch, Edward L. Murphy, Hua Shan, Paul Ness, Simone A. Glynn, The National Heart, Lung, and Blood Institute Recipient Epidemiology and Donor Evaluation Study (REDS-III): a research program striving to improve blood donor and transfusion recipient outcomes, Transfusion, 2014, 54, 3pt2
  7. 7
    M. Lozano, J. Cid, Analysis of reasons for not implementing pathogen inactivation for platelet concentrates, Transfusion Clinique et Biologique, 2013, 20, 2, 158

    CrossRef

  8. 8
    Jay S. Epstein, Harold W. Jaffe, Harvey J. Alter, Harvey G. Klein, Blood system changes since recognition of transfusion-associated AIDS, Transfusion, 2013, 53, 10pt2
  9. You have free access to this content9
    M. Goldman, Donor selection for recipient safety, ISBT Science Series, 2013, 8, 1
  10. 10
    Aryeh Shander, Sherri Ozawa, Irwin Gross, David Henry, Erythropoiesis-stimulating agents: friends or foes?, Transfusion, 2013, 53, 9
  11. 11
    Peter M. van der Kraan, Stem Cell Therapy in Osteoarthritis: A Step Too Far?, BioDrugs, 2013, 27, 3, 175

    CrossRef

  12. 12
    Christophe Michel Raynaud, Arash Rafii, The Necessity of a Systematic Approach for the Use of MSCs in the Clinical Setting, Stem Cells International, 2013, 2013, 1

    CrossRef

  13. 13
    Marion C. Lanteri, Michael P. Busch, Dengue in the context of “safe blood” and global epidemiology: to screen or not to screen?, Transfusion, 2012, 52, 8